These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

755 related articles for article (PubMed ID: 23666487)

  • 41. Mitochondrial biology, targets, and drug delivery.
    Milane L; Trivedi M; Singh A; Talekar M; Amiji M
    J Control Release; 2015 Jun; 207():40-58. PubMed ID: 25841699
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Mitochondrial medicine for neurodegenerative diseases.
    Du H; Yan SS
    Int J Biochem Cell Biol; 2010 May; 42(5):560-72. PubMed ID: 20067840
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Mitochondrial DNA and primary mitochondrial dysfunction in Parkinson's disease.
    Giannoccaro MP; La Morgia C; Rizzo G; Carelli V
    Mov Disord; 2017 Mar; 32(3):346-363. PubMed ID: 28251677
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Treatment of mitochondrial diseases strengthening mitochondria by stimulating glycolysis with insulin.
    Halabe Bucay A
    Med Hypotheses; 2008 Dec; 71(6):979-80. PubMed ID: 19117536
    [No Abstract]   [Full Text] [Related]  

  • 45. Drug-therapy networks and the prediction of novel drug targets.
    Spiro Z; Kovacs IA; Csermely P
    J Biol; 2008 Jul; 7(6):20. PubMed ID: 18710588
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Perspectives and potential applications of mitochondria-targeted antioxidants in cardiometabolic diseases and type 2 diabetes.
    Rocha M; Apostolova N; Herance JR; Rovira-Llopis S; Hernandez-Mijares A; Victor VM
    Med Res Rev; 2014 Jan; 34(1):160-89. PubMed ID: 23650093
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Human ClpP protease, a promising therapy target for diseases of mitochondrial dysfunction.
    Luo B; Ma Y; Zhou Y; Zhang N; Luo Y
    Drug Discov Today; 2021 Apr; 26(4):968-981. PubMed ID: 33460621
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Conjugation of Triphenylphosphonium Cation to Hydrophobic Moieties to Prepare Mitochondria-Targeting Nanocarriers.
    Guzman-Villanueva D; Mendiola MR; Nguyen HX; Yambao F; Yu N; Weissig V
    Methods Mol Biol; 2019; 2000():183-189. PubMed ID: 31148015
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Mitochondrial therapeutic interventions in Alzheimer's disease.
    Van Giau V; An SSA; Hulme JP
    J Neurol Sci; 2018 Dec; 395():62-70. PubMed ID: 30292965
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Mitochondria: prospective targets for neuroprotection in Parkinson's disease.
    Yadav A; Agarwal S; Tiwari SK; Chaturvedi RK
    Curr Pharm Des; 2014; 20(35):5558-73. PubMed ID: 24606805
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Concise Review: Induced Pluripotent Stem Cell-Based Drug Discovery for Mitochondrial Disease.
    Inak G; Lorenz C; Lisowski P; Zink A; Mlody B; Prigione A
    Stem Cells; 2017 Jul; 35(7):1655-1662. PubMed ID: 28544378
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Mitochondria: A Therapeutic Target for Parkinson's Disease?
    Luo Y; Hoffer A; Hoffer B; Qi X
    Int J Mol Sci; 2015 Sep; 16(9):20704-30. PubMed ID: 26340618
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Nrf2/ARE Pathway as a Therapeutic Target for the Treatment of Parkinson Diseases.
    Gureev AP; Popov VN
    Neurochem Res; 2019 Oct; 44(10):2273-2279. PubMed ID: 30617864
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Mitochondrial targets for arrhythmia suppression: is there a role for pharmacological intervention?
    Akar FG
    J Interv Card Electrophysiol; 2013 Sep; 37(3):249-58. PubMed ID: 23824789
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Integrated pathways of parkin control over mitochondrial maintenance - relevance to Parkinson's disease pathogenesis.
    Gaweda-Walerych K; Zekanowski C
    Acta Neurobiol Exp (Wars); 2013; 73(2):199-224. PubMed ID: 23823983
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Early Expression of Parkinson's Disease-Related Mitochondrial Abnormalities in PINK1 Knockout Rats.
    Villeneuve LM; Purnell PR; Boska MD; Fox HS
    Mol Neurobiol; 2016 Jan; 53(1):171-186. PubMed ID: 25421206
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Mitophagy and Parkinson's disease: be eaten to stay healthy.
    de Vries RL; Przedborski S
    Mol Cell Neurosci; 2013 Jul; 55():37-43. PubMed ID: 22926193
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Mitochondrial function in normal and diabetic beta-cells.
    Maechler P; Wollheim CB
    Nature; 2001 Dec; 414(6865):807-12. PubMed ID: 11742413
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Emerging concepts of mitochondrial dysfunction in Parkinson's disease progression: Pathogenic and therapeutic implications.
    Rani L; Mondal AC
    Mitochondrion; 2020 Jan; 50():25-34. PubMed ID: 31654753
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Targeting mitochondrial biogenesis for preventing and treating insulin resistance in diabetes and obesity: Hope from natural mitochondrial nutrients.
    Liu J; Shen W; Zhao B; Wang Y; Wertz K; Weber P; Zhang P
    Adv Drug Deliv Rev; 2009 Nov; 61(14):1343-52. PubMed ID: 19716392
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 38.